key: cord-0914038-ai422cah
authors: Huo, Yan; Zhang, Kun; Li, Bin; Hu, Zhen-jie
title: Patients with severe novel coronavirus pneumonia: from treatment to prevention
date: 2021-12-21
journal: Asian J Surg
DOI: 10.1016/j.asjsur.2021.12.004
sha: 170c972b67fcd7d0f340489ef66793691ad48b71
doc_id: 914038
cord_uid: ai422cah

nan

To the editor, In most COVID-19 patients, the main clinical manifestations of infection are fever, fatigue, and a dry cough. And some will progress to become patients with severe COVID-19 pneumonia, leading to ARDS, circulatory failure, and multi-organ dysfunction and need to be transferred to the Intensive Care Unit (ICU) for treatment.

angiotensin-converting enzyme 2(ACE2). Thus cellular shedding and apoptosis occur after injury, promoting proliferation of pulmonary fibroblast and increasing pulmonary vascular permeability, which play an important role in inducing lung injury in acute viral pneumonia. Secondary injuries are mainly correlated with inappropriate stress response, abnormally driven autonomic respiration and increased circulatory kinetics, together with mechanical ventilation-related injuries. These will result in a simultaneous increase in trans-pulmonary pressure and trans-vascular pressure accompanied by a concomitant increase in pulmonary blood flow, which will lead to significant interstitial microvascular endothelial There still exist some other lung protection measures as follows:

① Administration of the anti-stress drugs, e.g., β-blockers, dexmedetomidine, etc. 

ARDS Definition Task Force et al. Acute respiratory distress syndrome: the Berlin Definition

Fluid Therapy and Acute Respiratory Distress Syndrome

Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study

Acute Respiratory Distress Syndrome Network et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome